Analytical Data
-
基因名
SPDYA
- Application
-
别名
SPDYA; SPDY1; SPY1; Speedy protein A; Rapid inducer of G2/M progression in oocytes A; RINGO A; hSpy/Ringo A; Speedy-1; Spy1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5MJ70
-
表达区间
1-313aa
-
氨基酸序列
MRHNQMCCET PPTVTVYVKS GSNRSHQPKK PITLKRPICK DNWQAFEKNT HNNNKSKRPK GPCLVIQRQD MTAFFKLFDD DLIQDFLWMD CCCKIADKYL LAMTFVYFKR AKFTISEHTR INFFIALYLA NTVEEDEEET KYEIFPWALG KNWRKLFPNF LKLRDQLWDR IDYRAIVSRR CCEEVMAIAP THYIWQRERS VHHSGAVRNY NRDEVQLPRG PSATPVDCSL CGKKRRYVRL GLSSSSSLSS HTAGVTEKHS QDSYNSLSMD IIGDPSQAYT GSEVVNDHQS NKGKKTNFLK KDKSMEWFTG SEE
-
分子量
36.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SPDYA (SPRY Domain-containing Protein A) is a protein implicated in various cellular processes, including cell proliferation, differentiation, and apoptosis. Its role in the regulation of signal transduction pathways has garnered increasing interest in the field of molecular biology and biomedical research. SPDYA has been studied for its potential involvement in cancer progression, as its expression levels can be altered in various tumor types, suggesting a possible link to oncogenesis. Understanding the biochemistry and structure of SPDYA is crucial for elucidating its functional mechanisms and potential as a therapeutic target. Recent advancements in protein engineering and recombinant DNA technology have enabled researchers to produce and purify SPDYA in significant quantities, facilitating in-depth studies. Investigating the effects of SPDYA's molecular interactions, post-translational modifications, and its role in the cellular microenvironment may provide insights into its biological significance and therapeutic potential. This research is particularly relevant in the context of developing targeted therapies for diseases where SPDYA is dysregulated. Overall, the study of SPDYA and its recombinant protein forms represents a promising area of research with implications for understanding complex cellular functions and designing innovative medical treatments.
